Evaluation of US2019070266 patent, treatment diabetic foot ulcers with Liraglutide

Simple item page
dc.contributor.authorPérez-Santos, Martín
dc.date.accessioned2020-11-27T06:17:16Z
dc.date.available2020-11-27T06:17:16Z
dc.date.issued2020-03-16
dc.description.abstractDiabetic foot ulcers are clinical complications that affect to a 15-25% of patients of type-2 diabetes mellitus and are responsible for more hospitalizations than any other complication of diabetes. Authors of US2019070266 patent propose a method for treatment of diabetic foot ulcers. US2019070266 describes a method that consists of the administration of Liraglutide, at a dose of 1.2-1.8 mg, in patients with type 2 diabetes and with at least one risk factor for vascular disease, such as microalbuminuria, proteinuria, hypertension, left ventricular hypertrophy, left ventricular systolic dysfunction, left ventricular diastolic dysfunction and ankle/brachial index <0.9. The results of the clinical trials support the therapy’s efficacy; however, the invention is not new considering art state, whereby, new studies will be necessary to determine other administration routes, e.g. topical, dose and time of administration of Liraglutide.es_MX
dc.identificatorAyTBUAP 5(17):52-58es_MX
dc.identifier.citationPerez-Santos M. Evaluation of US2019070266 patent, treatment diabetic foot ulcers with Liraglutide. Alianzas y Tendencias BUAP. 2020 Mar 17;5(17):52. Available from: https://www.aytbuap.mx/publicaciones#h.38aimu2eznines_MX
dc.identifier.issn2594-0627
dc.identifier.otherhttps://eoi.citefactor.org/10.11235/BUAP.05.17.04
dc.identifier.otherhttps://www.aytbuap.mx/editorial-517-cambios-urgentes-en-las-pr%C3%A1cticas-agr%C3%ADcolas-para-mitigar/evaluation-of-us2019070266-patent-treatment-diabetic-foot-ulcers-with-lira
dc.identifier.urihttps://hdl.handle.net/20.500.12371/9396
dc.language.isospaen_USA
dc.publisherBenemérita Universidad Autónoma de Pueblaen_USA
dc.relation.ispartofseriesVolumen 5;Número 17es_MX
dc.subjectLiraglutideen_USA
dc.subjectdiabetic footen_USA
dc.subjectpatenten_USA
dc.subjectdiabetesen_USA
dc.subjectulceren_USA
dc.titleEvaluation of US2019070266 patent, treatment diabetic foot ulcers with Liraglutideen_USA
dc.typeArtículoes_MX
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
6 Liraglutide in diabetic foot ulcer US2019070266.pdf
Size:
392.33 KB
Format:
Adobe Portable Document Format
Description:
AyTBUAP 5(17):52-58
Download
License bundle
Now showing 1 - 1 of 1
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Revista Alianzas y Tendencias BUAP (AyTBUAP)